Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 New Company Offers a 'New Prescription for Profits' - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

New Company Offers a ‘New Prescription for Profits’

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Pharm Nutra, New York, NY, has introduced a service that provides another chance for pharmaceuticals that have failed some phase of the clinical trials process to enter the nutraceuticals market. The company reviews product portfolios that have failed the clinical trials process due to insurmountable technical problems such as, for example, not reaching certain bioavailability thresholds—those products that would be marketable as OTC/dietary supplements are identified. Pharm Nutra then positions products under DSHEA (Dietary Supplement Health and Education Act), allowing the crossover from drug application to dietary supplement. Once ideal candidate products are identified, Pharm Nutra utilizes its contact base to find the right partners who will license the formulas, and manufacture and distribute under their own brands. The products can then be sold in health food store chains and independents, chain drug, mass market, independent and discount retailers.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics